Category Archives: Cardiology

New report finds action is required to protect UK health research – Imperial College London

A new report from the Academy of Medical Sciences has outlined that the UK needs to do more to retain its exceptional strengths in health research.

The report titled Future-proofing UK Health Research: a people-centred, coordinated approachwas produced by 30 experts from across the UK, including Imperials Dr Rasha Al-Lamee, Clinical Senior Lecturer at the National Heart and Lung Institute, Imperial College London and cardiology consultant Imperial College Healthcare NHS Trust.

The report calls for coordinated action to secure a sustainable future for research and deliver maximum health benefits for people everywhere, which involves Governments across the UK, public and charitable funders, higher education institutions, industry, NHS leaders, patients, carers and the public.

Listen to Dr Al-Lamee on BBC Radio 4 Today Programme(from 51m 53s)

It concludes that UK health research is in danger of being taken for granted and sets out what needs to be done to improve and future-proof it.

The importance of clinical academics was highlighted as being crucial to support the over-burdened NHS and calls on regulators, funders, the NHS and universities to improve support for clinical academics and pilot a scheme where healthcare professionals have protected time for research.

Dr Rasha Al-Lamee works jointly between Imperials National Heart and Lung Institute and as a cardiology consultant at Imperial College Healthcare NHS Trust and spends 70% of her work-life running clinical trials on how to relieve the symptoms of heart disease and 30% of her time seeing patients.

Dr Al-Lamee noted that"hospitals doing research have better patient outcomes overall.

Despite this, there has been a decline of almost a quarter of the number of clinical academics at my career level across the UK over the last decade.

To avoid detrimental effects on patients and healthcare workers like me, the sector needs to make it easier to hold these dual careers in a secure and flexible way.

Some ofthe report's other key findings include the need to place people at the heart of the UK health research system by improving research culture and career structures, maximise the research potential of the NHS and, crucially, ensure that the true cost of excellent health research is adequately covered by addressing the current model of research funding where universities are required to cross-subsidise research costs from international student fee income.

Original post:

New report finds action is required to protect UK health research - Imperial College London

Common Sedative vs Afib; Fishbone Pierces Heart; Oral PCSK9 … – Medpage Today

When people actually prove their adherence to the Mediterranean diet using blood tests, this eating pattern was associated with stronger protection from type 2 diabetes than previously thought. (PLOS Medicine)

The global burden of cardiovascular deaths attributable to very cold and very hot temperatures increased from 1990 to 2019. (European Journal of Preventive Cardiology)

The common sedative dexmedetomidine was associated with reduced new-onset atrial fibrillation (Afib) in ICU patients. (JAMA Network Open)

Afib was associated with an overabundance of certain species in the gut microbiome. (eBioMedicine)

Procedural efficacy was high in the early experience with the new Heliostar irrigated radiofrequency balloon, which was designed to give operators impedance values that quantify the grade of contact during pulmonary vein isolation. (EP Europace)

An interatrial shunt without a permanent implant? Radiofrequency-energy excision of the interatrial septum showed promise in terms of pulmonary capillary wedge pressure and functional improvement at 6 months. (JACC: Heart Failure)

DELIVER trial participants derived consistent benefits from dapagliflozin (Farxiga) across the spectrum of ejection fraction. (JAMA Cardiology)

The case where a swallowed fishbone, nearly an inch long, pierced through the heart into the left atrium and caused a Staphylococcus aureus infection. (European Heart Journal)

FDA cleared the Heart Seat -- a smart toilet seat that measures heart rate and oxygen saturation -- maker Casana announced.

Medtronic said the FDA approved its next-generation Micra AV2 and VR2 leadless pacemakers featuring 40% more battery life than older devices.

The Endurant abdominal aortic aneurysm stent graft system boasted 94.7% freedom from aneurysm-related mortality and 64.1% sac regression in 10-year postmarketing data, Medtronic also announced.

Among young people who survive acute myocardial infarction (MI), women are disproportionately more likely to be rehospitalized for cardiac and noncardiac reasons. (Journal of the American College of Cardiology)

After coronary artery bypass grafting, subsequent angioplasty on the graft, as opposed to the native artery, was tied to a higher 5-year MI risk. (Clinical Cardiology)

Merck scientists report phase I data supporting the macrocyclic peptide MK-0616 as an oral PCSK9 inhibitor that may lower LDL cholesterol. (Circulation)

People with more painful areas on their body were prone to MI but not stroke. (JACC: Advances)

In 2000-2014, Black Americans with better survival rates tended to be those born in Africa, the Caribbean, South America, and Central America. (Journal of the American Heart Association)

A country with fewer than 10 cardiac specialists, Zambia just had its first total aortic arch replacement surgery with guidance from University of Michigan surgeons. (Michigan Medicine)

MPI 8, an anticoagulant targeting polyphosphate, is being developed for potential clinical use without bleeding side effects. (Nature Communications)

Scientists are hoping that their "vein on a chip" could be a good lab model of blood clot formation, according to the University of Birmingham.

Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. Follow

Read this article:

Common Sedative vs Afib; Fishbone Pierces Heart; Oral PCSK9 ... - Medpage Today

More Rehospitalizations for Younger Women 1-Year Post-MI – Medscape

Younger women (those aged 18-55) have more adverse outcomes than men in the year after an acute myocardial infarction (AMI) and are at greater risk for both cardiac and noncardiac rehospitalizations, a new analysis of the VIRGO study suggests.

All-cause hospitalization rates within 1 year of discharge were 34.8% for women compared with 23% for men. Most hospitalizations for women were coronary-related.

Women with a myocardial infarction with nonobstructive coronary arteries (MINOCA) had lower rates of rehospitalization than women who experienced myocardial infarction with obstructive coronary artery disease (MI-CAD).

There was a more significant sex disparity between women and men for noncardiac hospitalizations compared with all other hospitalizations (incidence rate, 145.8 [women] vs 69.6 [men] per 1000 person-years).

"We were surprised to see the significance of sex difference in 1-year outcomes despite adjusting for over 30 variables, variables that often hold significant impact, such as belonging in the self-reported non-Hispanic Black population and lower socioeconomic status, [and] scores on health status questionnaires," Mitsuaki Sawano, MD, PhD, of the Yale School of Medicine, New Haven, Connecticut, told theheart.org | Medscape Cardiology. "Our findings indicate that women may indeed be at higher risk for 1-year hospitalizations."

Comprehensive data capturing healthcare utilization in young patients with AMI is lacking in the United States, Sawano said. "That is exactly why the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients) study started more than decade ago."

"Since there is no indication that much has changed in the care provided to young patients over the last decade, we think the data from VIRGO remains relevant to this day," he added.

The results were published online May 1 in the Journal of the American College of Cardiology.

The VIRGO study enrolled men and women with AMI across 103 US hospitals. Average age of the patients was 47 years and 70% self-identified as non-Hispanic White. A high proportion of women self-identified as non-Hispanic Black compared with men.

Women also had a higher prevalence of comorbidities, including obesity, congestive heart failure, prior stroke, and renal disease, and a greater history of depression at baseline (48.7% vs 24.2%).

Among the 2979 patients (67% women) included in the analysis, at least one hospitalization occurred in 905 (30.4%) in the year after discharge.

The leading causes of hospitalization were coronary-related (incidence rate [IR], 171.8 among women vs 117.8 among men), followed by noncardiac hospitalization (IR, 145.8 vs 69.6) and dissection and vasospasm (1.4% vs 0.2%).

Women with MINOCA had a lower incidence of 1-year all-cause, coronary-related, and stable or unstable angina hospitalizations compared with women with MI-CAD. The women with MINOCA also reported lower treatment satisfaction compared with men or women presenting with MI-CAD.

At the time of discharge, the total length of stay was longer for women vs men, and women received lower rates of guideline-recommended medical therapies, including aspirin (92.6% vs 95%), statins (67.5% vs 71.7%), beta-blockers (89.6% vs 94.1%), and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (61.2% vs 70.6%).

"Greater burden of risk factors, chest discomfort symptoms deemed 'noncardiac,' delays in hospital presentation, delays in care after arriving at the hospital, inequalities in timely reperfusion therapies or any revascularization, lower prescription and continuation rate of optimal medical therapy, etc. all have been proposed as contributing factors to worse clinical outcomes in young women," Sawano said. "More importantly, we have not seen any full-scale attempts to lessen sex disparity."

To minimize the risk of avoidable hospitalizations, a multidisciplinary team of cardiologists, psychiatrists, ob/gyn doctors, diabetes clinicians, and obesity specialists, among others, "is warranted during the index hospitalization," he added.

"Clinicians would need to understand the patient better," including factors like financial status, insurance, access to healthcare, and possible constraints related to household roles. "All are relevant to taking care of the young patients," he said.

"I am not surprised by the current findings, as young women are the least aware of their risk for heart attacks," American Heart Association volunteer expert Nieca Goldberg, MD, clinical associate professor of medicine at NYU Grossman School of Medicine andmedical director of Atria, New York City, told theheart.org | Medscape Cardiology. "The current health system seems fixed on the image of men and older women being at risk for heart disease. A different analysis will likely have the same results."

Physicians need to look beyond traditional risk factors like high blood pressure, high cholesterol, family history, cigarette smoking, lack of exercise and obesity, she said. "They should incorporate questions about autoimmune disease and pregnancy-related disorders such as preeclampsia, gestational diabetes, preterm birth as well as mental health issues like depression, anxiety, and stress. These disorders can widen out the net of women who are at risk for heart disease."

Martha Gulati, MD, MS, Cedars-Sinai Smidt Heart Institute, Los Angeles, California, and colleagues conclude in a related editorial that the new analysis "adds to decades worth of literature clearly illustrating that young women with AMI experience more adverse outcomes than men.

"The disparities are evident," they conclude. "Now it is time to stop adding insult to infarct and to solve these persistent sex gaps in cardiovascular care."

The VIRGO study (NCT00597922) was supported by the National Heart, Lung, and Blood Institute. Sawano reports no relevant financial relationships, but several co-authors report ties to industry; the full list can be found with the original article. The editorialists and Goldberg report no relevant financial relationships.

J Am Coll Cardiol. Published online May 1, 2023. Abstract, Editorial

Follow Marilynn Larkin on Twitter:@MarilynnL.

For more from theheart.org | Medscape Cardiology, join us on Twitter and Facebook

Read more from the original source:

More Rehospitalizations for Younger Women 1-Year Post-MI - Medscape

PET Nuclear Medicine Market By Applications ( Oncology, Cardiology, Neurology, Other PET Applications ) – openPR

PET Nuclear Medicine Market

Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00015978/?utm_source=OpenPR&utm_medium=10379

Key Players Analysis: Cardinal Health Curium GE Healthcare Lantheus Medical Imaging, Inc. Bayer AG Bracco Imaging S.P.A. Eczacibasi-Monrol Nuclear Products Nordion, Inc. (A Subsidiary of Sterigenics International) Advanced Accelerator Applications (AAA) (A Part of Novartis) NTP Radioisotopes Soc, LTD.

The report covers key developments in the PET Nuclear Medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PET Nuclear Medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for PET Nuclear Medicine in the global market. Below mentioned is the list of few companies engaged in the PET Nuclear Medicine market.

Speak to Analyst @ https://www.theinsightpartners.com/speak-to-analyst/TIPRE00015978?utm_source=OpenPR&utm_medium=10379

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behavior & the growth of the market as well as industries.

MARKET SEGMENTATIONThe PET nuclear medicine market is segmented on the basis of type and application. Based on type, the market is segmented as F-18, Rb-82, Other PET Isotopes. On the basis of application, the market is categorized as oncology, cardiology, neurology, and other pet applications.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PET Nuclear Medicine Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PET Nuclear Medicine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Get a Full Copy @ https://www.theinsightpartners.com/buy/TIPRE00015978/?utm_source=OpenPR&utm_medium=10379

Contact USContact Person : Sameer JoshiPhone : +1-646-491-9876E-mail : sales@theinsightpartners.com

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

See more here:

PET Nuclear Medicine Market By Applications ( Oncology, Cardiology, Neurology, Other PET Applications ) - openPR

Statin Misinformation on Social Media Flagged by AI – Medscape

Using artificial intelligence (AI) to analyze large amounts of information from social media platforms generated some novel insights into public perceptions about statins, results of a new study show.

The study, which used AI to analyze discussions about statins on the social media platform Reddit, corroborated previously documented reasons for statin hesitancy, including adverse effect profiles, and general disenfranchisement with healthcare.

But it also found novel points of discourse including linking statins to COVID-19 outcomes, and the role of cholesterol, statins, and the ketogenic diet.

"We used AI to tell us what is being discussed about statins on social media and to quantify the information in topics that people think are important," senior study author Fatima Rodriguez, MD, MPH, Stanford University School of Medicine, Stanford, California, told theheart.org | Medscape Cardiology.

"Some of the themes were surprising to us. While we expected discussion on side effects, we were surprised to see so much discussion refuting the idea that increased levels of LDL were detrimental. There were also a large amount of posts on statin use being correlated to COVID outcomes. Our findings show how widespread this misinformation is," she said.

"As a preventative cardiologist I spend a lot of my time trying to get patients to take statins, but patients often rely on social media for information, and this can contain a lot of misinformation.

"People tend to be more honest on online forums than they are in the doctor's office, so they are probably asking the questions and having discussions on subjects they really care about. So, understanding what is being discussed on social media is very valuable information for us as clinicians."

The study was published online April 24 in JAMA Network Open.

The researchers analyzed all statin-related discussions on Reddit that were dated between January 1, 2009, and July 12, 2022. Statin- and cholesterol-focused communities were identified to create a list of statin-related discussions. An AI pipeline was developed to cluster these discussions into specific topics and overarching thematic groups.

A total of 10,233 unique statin-related discussions and 5,188 unique authors were identified. A total of 100 discussion topics were identified and classified into six overarching thematic groups: (1) ketogenic diets, diabetes, supplements, and statins; (2) statin adverse effects; (3) statin hesitancy; (4) clinical trial appraisals; (5) pharmaceutical industry bias and statins; and (6) red yeast rice and statins.

Several examples of statin-related misinformation were identified, including distrust of the hypothesis that LDL-C has a causal association with heart disease. Discussions included quotes such as "I think LDL is pretty much irrelevant. Your HDL and triglycerides are far more important."

Other topics suggested that certain natural supplements would be an acceptable alternative to statins. Quotes included: "Red yeast rice is a statin basically, by the way," and "statins are basically mycotoxins and deplete you of fat-soluble nutrients, like coQ10, vit D, K, A and E, and in all likelihood through these depletions worsen cardiovascular health."

The researchers also looked at temporal trends and found that these sorts of discussions have increased over time.

One of the common themes identified was using the ketogenic diet phenomenon as an argument against increased cholesterol levels being bad for health.

Rodriguez elaborated: "People think the ketogenic diet is healthy as they lose weight on it. And as it can be associated with a small increase in LDL cholesterol there was a lot of opinion that this meant increasing LDL was a good thing."

The researchers also conducted a sentiment analysis, which designated topics as positive, negative or neutral with regard to statins.

"We found that almost no topic was positive. Everything was either neutral or negative.This is pretty consistent with what we are seeing around hesitancy in clinical practice, but you would think that maybe a few people may have a positive view on statins," Rodriguez commented.

"One of the problems with statins and lowering cholesterol is that it takes a long time to see a benefit, but this misinformation will result in some people not taking their medication," she added.

Rodriguez noted that in this study AI is augmenting, not replacing, what clinicians and researchers do. "But it is a valuable tool to scan a large volume of information, and we have shown here it can generate new insights that we may not have thought of.It's important to know what's out there so we can try and combat it."

She pointed out that patients don't read the medical literature showing the benefits of statins but rather rely on social media for their information.

"We need to understand all sorts of patient engagement and use the same tools to combat this misinformation. We have a responsibility to try and stop dangerous and false information from being propagated," she commented.

"These drugs are clearly not dangerous when used in line with clinical guidelines and they have been proven to have multiple benefits again and again, but we don't see those kinds of discussions in the community at all. We as clinicians need to use social media and AI to give out the right information. This could start to combat all the misinformation out there."

JAMA Network Open. Published online April 24, 2023. Full text

For more from theheart.org | Medscape Cardiology, join us on Twitter and Facebook

Continue reading here:

Statin Misinformation on Social Media Flagged by AI - Medscape

Mobile phone calls linked with increased risk of high blood pressure – EurekAlert

Sophia Antipolis, 5 May 2023: Talking on a mobile for 30 minutes or more per week is linked with a 12% increased risk of high blood pressure compared with less than 30 minutes, according to research published today in European Heart Journal Digital Health, a journal of the European Society of Cardiology (ESC).1

Its the number of minutes people spend talking on a mobile that matter for heart health, with more minutes meaning greater risk, said study author Professor Xianhui Qin of Southern Medical University, Guangzhou, China. Years of use or employing a hands-free set-up had no influence on the likelihood of developing high blood pressure. More studies are needed to confirm the findings.

Almost three-quarters of the global population aged 10 and over own a mobile phone.2 Nearly 1.3 billion adults aged 30 to 79 years worldwide have high blood pressure (hypertension).3 Hypertension is a major risk factor for heart attack and stroke and a leading cause of premature death globally. Mobile phones emit low levels of radiofrequency energy, which has been linked with rises in blood pressure after short-term exposure. Results of previous studies on mobile phone use and blood pressure were inconsistent, potentially because they included calls, texts, gaming, and so on.

This study examined the relationship between making and receiving phone calls and new-onset hypertension. The study used data from the UK Biobank. A total of 212,046 adults aged 37 to 73 years without hypertension were included. Information on the use of a mobile phone to make and receive calls was collected through a self-reported touchscreen questionnaire at baseline, including years of use, hours per week, and using a hands-free device/speakerphone. Participants who used a mobile phone at least once a week to make or receive calls were defined as mobile phone users.

The researchers analysed the relationship between mobile phone usage and new-onset hypertension after adjusting for age, sex, body mass index, race, deprivation, family history of hypertension, education, smoking status, blood pressure, blood lipids, inflammation, blood glucose, kidney function and use of medications to lower cholesterol or blood glucose levels.

The average age of participants was 54 years, 62% were women and 88% were mobile phone users. During a median follow up of 12 years, 13,984 (7%) participants developed hypertension. Mobile phone users had a 7% higher risk of hypertension compared with non-users. Those who talked on their mobile for 30 minutes or more per week had a 12% greater likelihood of new-onset high blood pressure than participants who spent less than 30 minutes on phone calls. The results were similar for women and men.

Looking at the findings in more detail, compared to participants who spent less than 5 minutes per week making or receiving mobile phone calls, weekly usage time of 30-59 minutes, 1-3 hours, 4-6 hours and more than 6 hours was associated with an 8%, 13%, 16% and 25% raised risk of high blood pressure, respectively. Among mobile phone users, years of use and employing a hands-free device/speakerphone were not significantly related to the development of hypertension.

The researchers also examined the relationship between usage time (less than 30 minutes vs. 30 minutes or more) and new-onset hypertension according to whether participants had a low, intermediate or high genetic risk of developing hypertension. Genetic risk was determined using data in the UK Biobank. The analysis showed that the likelihood of developing high blood pressure was greatest in those with high genetic risk who spent at least 30 minutes a week talking on a mobile they had a 33% higher likelihood of hypertension compared to those with low genetic risk who spent less than 30 minutes a week on the phone.

Professor Qin said: Our findings suggest that talking on a mobile may not affect the risk of developing high blood pressure as long as weekly call time is kept below half an hour. More research is required to replicate the results, but until then it seems prudent to keep mobile phone calls to a minimum to preserve heart health.

ENDS

Authors:ESC Press OfficeMobile: +33 (0)7 8531 2036Email:press@escardio.org

Follow us on Twitter @ESCardioNews

Funding: The study was supported by the National Key Research and Development Program (2022YFC2009600, 2022YFC2009605), and the National Natural Science Foundation of China (81973133, 81730019).

Disclosures: The authors have no conflicts of interest to report.

References

1Ye Z, Zhang Y, Zhang Y, et al. Mobile phone calls, genetic susceptibility and new-onset hypertension: results from 212,046 UK Biobank participants. Eur Heart J Digit Health. 2023. doi:10.1093/ehjdh/ztad024.

Link will go live on publication:

https://academic.oup.com/ehjdh/article-lookup/doi/10.1093/ehjdh/ztad024

2International Telecommunication Union. Measuring digital development: facts and figures 2022. https://www.itu.int/hub/publication/d-ind-ict_mdd-2022/

3World Health Organization. Key facts on hypertension. https://www.who.int/news-room/fact-sheets/detail/hypertension.

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

About European Heart Journal Digital Health

European Heart Journal Digital Health is the official digital health journal of the European Society of Cardiology. It covers the whole sphere of cardiovascular medicine, from all perspectives of digital health.

European Heart Journal - Digital Health

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

More:

Mobile phone calls linked with increased risk of high blood pressure - EurekAlert

Radiation Scatter 101: Risks, Dangers and Latest Solutions – Diagnostic and Interventional Cardiology

Invented in 1896 by Enrico Salvioni, the fluoroscope remains a flagship technology of modern medicine. The live video X-ray image it provides can guide a catheter safely through a living patients circulatory system, delivering a therapeutic action precisely where needed. As an interventional cardiologist, Id be blind without my fluoroscope, and the life-saving procedures it permits would be impossible.

Unfortunately, the machines great power comes from the X-ray beam it uses to penetrate and image the human bodys interior. The very high frequency, short wavelength electromagnetic radiation generated in its X-ray tube is a well-known danger to living beings, and must be very carefully controlled. Most of us who work with radiation in medical applications believe we are controlling it, but that may stem more from complacency than from facts.

Within the last decade, studies have revealed that interventional cardiology and cardiac electrophysiology staff experience increased rates of cancer, skin lesions, cataracts and orthopedic illnesses as compared with their unexposed colleagues, even though they had adhered to international and federal radiation dose limits. These maladies increased with the amount of time spent conducting interventions.

While the diagnostic and treatment benefits of radiologic medicine are far too valuable to give up, we deny its downside at our peril: an increased risk of debilitating and potentially lethal health effects for the doctors, nurses, technicians and other staff who work in the catheterization lab daily and absorb small amounts of scatter radiation repeatedly over the course of their careers.

This risk is compounded by the trend toward higher-power machines to produce sharper images. Its the Catch-22 of a life in the catheterization lab: the better fluoroscopes get at helping our patients, the more they seem to hurt our healthcare team.

While most healthcare providers know about the dangers of direct radiation and take steps to avoid exposure, the threat of scatter radiation is less commonly understood. But over time, it can be just as dangerous. To help them grasp the concept, I tell my students to think of a high-tech heist movie, where the treasure to be stolen is protected behind a wall of crisscrossing laser beams: when you break one beam the alarm sounds. Its much the same with scatter radiation in the cath lab, except that the beams are invisible and harmful, and no alarm sounds when we move through them.

Thats why its a good idea, from time to time, to refresh our understanding of the risks and dangers of scatter radiation during fluoroscopic interventions, along with the best practices and new technologies that are making it easier to stay safer in the cath lab. With these in place, we no longer have to choose between improving our patients health and protecting our own.

Over more than a century using radiation in medical applications, weve learned a lot about what it can do, for better and worse. Unseen but for the damage it leaves behind, ionizing radiation is dangerous both acutely in higher doses and cumulatively in lower doses over time, as happens with scatter radiation in the catheterization lab.

The damage it can wreak on the human body takes one or more of the following forms:

Direct effects. These injuries result from acute overexposure to a directed radiation beam or proximity to a radioactive substance such as uranium, and can include all levels of burns to the skin and underlying tissue, radiation sickness, and death. Modern medical equipment is designed to prevent such massive overdoses.

Stochastic effects. Like an insidious poison, low doses of radiation repeated over time can increase ones risk of acquiring naturally occurring cancers. This is because radiation damages the genetic code deep within cell nuclei, increasing the chance that mistakes in the repair process could lead to a cancer-causing mutation to be incorrectly inserted into ones DNA. Stochastic effects for cath lab staff also include cataracts and cognitive problems.

Genetic effects. Damage to a chromosome that is repaired with an incorrect sequence can cause serious genetic mayhem, and it can be passed on to subsequent generations.

Embryo and fetus effects. A developing child is particularly vulnerable to radiations dose-dependent effects, which can include death or congenital abnormalities that appear at birth or later in life.

For fluoroscope users like me, no list of radiations dangers would be complete without mentioning the pain, fatigue and occasionally debilitating effects caused by wearing heavy garments, an antiquated but still technically effective way to protect staff. In fact, Ive known cath lab colleagues who were forced to retire from the field due to long-term damage caused by these cumbersome devices. With 12 years of training required for each interventional cardiologist, losing them to back pain seems a terrible waste of resources. Thankfully, lighter, lead-free alternatives are proliferating along with non-apparel methods to protect the whole room, and these will form the core of an effective 21st century fix for the problem.

The solution to radiation exposure is radiation protection, and when it comes to policies that can best protect cath lab staff from scatter radiation, the guiding principle must be ALARA, the acronym for as low as reasonably achievable. It means in all instances ones mindset should be to use the minimum amount of radiation to get the job done and produce the least exposure. This is especially important when it comes to personal protective equipment, as forgetting to don it before entering the danger zone can lead to real trouble. A protective gear checklist to review when suiting up can help, as well as maintaining an environment where staff are encouraged to continually check each others safety status.

Time, distance, shielding and dose monitoring are the time-tested pillars of radiation protection in medical settings. Combined with an ALARA mindset, they imply the following directives:

Time. Minimize your time operating the fluoroscope or being in the room while its on.

Distance. Maximize your distance from the radiation source. Two steps away from the table cuts your exposure by half.

Shielding. Put as much shielding as possible between you and the radiation source.

Monitoring. Wear a personal dosimeter to monitor and gauge your exposure.

Ultimately, all cath lab staff should be fully educated on scatter radiations dangers and the policies, practices, and technologies in use to defeat it.

Fluoroscopic image quality can suffer from insufficient power, usually because the image is too noisy or cluttered for a low dose scan. High dose settings (sometimes called detail mode) can improve image quality by boosting contrast, but this sends more radiation to the patient and more scatter into the room. In practice most of the time, the low power setting produces an excellent though slightly less sharp image, with no practical reduction in diagnostic value.

The following habits can also minimize overexposure due to machine settings:

Higher magnification and frame rates increase radiation overall, so use lower settings for these features unless a higher one is necessary.

Use the fluoro save feature to save the last image and reduce the need for more imaging.

Place lead drapes under the patient table, avoiding obstructions to C-arm travel.

Put the X-ray source under the patient table as far away as possible to reduce scatter radiation by directing it through the table and patient before it reaches staff, and place the X-ray detector as close to the patent as possible to produce the sharpest image.

Use tubing extensions to maintain a two-step distance from the table during imaging.

Avoid using the fluoroscope if a non-radiological imaging device can do the job; ultrasound, magnetic resonance imaging (MRI), optical coherence tomography (OCT), intravascular ultrasound (IVUS) or transesophageal echo (TEE) might be a safer alternative.

Other factors that can affect radiation scatter include larger patients. Modern fluoroscopes with automatic brightness control (ABC) will increase their power to penetrate patients with thicker or denser than average bodies. In these cases, the fluoroscopist should check if the ABC can be turned off and still produce an acceptable image.

A technological fix is always tempting, but we must remember that scatter radiation is a problem that sprang from a previous technological fix the use of X-rays to image the inner body. Every device designed to solve this problem will likely have positive and negative aspects that warrant careful consideration, and you may have to change the way you practice to reap all the benefits they promise.

Anyone who has worn leaden shielding garments for this type of work will be quick to suggest lightening the load, and modern medical science is answering the call with lead-free alternatives that dramatically reduce weight without sacrificing shielding power. Removing toxic lead from shielding also prevents it from finding its way into our environment, which is another win for healthcare.

Companies such as RadPad and Vitalcare Products produce a range of lead-free pads, table skirts, drapes, and other innovative shield types that are sterilizable and disposable. They are a simple and less expensive way to put shielding where needed, they keep the ALARA principle alive, and they serve as a helpful adjunct to more complicated, high-tech systems.

The Zero-gravity drape wrap from TIDI Products is one such step up in technical complexity. It offers security, light weight and ease of movement through a suspended lead-acrylic head shield that protects the operator from overexposure while working with the fluoroscope. Its chief advantage is in reducing strain on the back, neck, shoulder, hips, knees and ankles.

Of course, the holy grail of cath lab radiation protection will be a system that protects everyone in the room, and early attempts at such systems have begun to appear.

For example, Egg Medicals EggNest cath lab table reduces overall scatter by up to 91%, and Ramparts IC M1 123 independently adjustable acrylic shielding panels give it multiple vascular access points and may block enough X-ray scatter that lead aprons are not required.

Radiaction Medicals approach to full room protection relies on intuitive controls and an ingenious design to reduce scatter radiation by up to 90%, with up to a 97% reduction to the operators head, face and neck. The device doesnt impede access to the patient, and data indicate it may eliminate the need for up to 75% of protective lead apparel. It attaches unobtrusively to the fluoroscopes C-arm and deploys robotically on command, extending shielding panels that conform to the patients body and to the rotational angle of the C-arm. Afterward, the Radiaction device retracts quickly, minimizing its small footprint even further.

The EggNest radiation protection system reduces radiation exposure without compromising workflow. Image courtesy of Egg Medical.

Safer fluoroscopic interventions are both possible and necessary, but addressing the dangers of scatter radiation in interventional suites requires a commitment from all involved, from staff who must religiously follow safety protocols to administrators who must provide appropriate, effective tools to ensure our workplace safety. Fortunately for all of us, awareness is spreading, technology is progressing, and a bright future of long, healthy careers in radiologic medicine is well within our grasp.

Mohammad Sahebjalal, MD, is an Interventional Consultant Cardiologist at Musgrove Park Hospital. He was appointed in 2017 making him, at the time, one of the youngest interventional consultants in the UK.

Radiaction Medical Announces the Latest Food and Drug Administration 510(k) Clearance for its Novel, Automated Radiation Shield System, Highlighting U.S. Expansion

Market for MRI-based Radiotherapy Could Soon Widen

Carestream Introduces SmartGrid Software to Reduce Effects of Scatter Radiation

Scatter Radiation from Mammography Presents No Cancer Risk

Link:

Radiation Scatter 101: Risks, Dangers and Latest Solutions - Diagnostic and Interventional Cardiology

PeaceHealth 1st in Oregon to earn American College of Cardiology … – Becker’s ASC Review

Springfield, Ore.-based PeaceHealth Sacred Heart Medical Center at RiverBend has become the first hospital in the state to receive the American College of Cardiology's Certified Transcather Valve Center designation.

The certification honors the facility for meeting the highest standards as determined by the ACC for transcatheter aortic valve replacement (TAVR) and Mitraclip procedures, according to an April 6 news release.

TAVR and Mitraclip procedures are less invasive alternatives to open heart repair or replacement.

The first TAVR was performed at the PeaceHealth facility in 2012, and since then, surgeons have performed more than 1,200.

Continued here:

PeaceHealth 1st in Oregon to earn American College of Cardiology ... - Becker's ASC Review